Sonnet BioTherapeutics
SONN
SONN
10 hedge funds and large institutions have $389K invested in Sonnet BioTherapeutics in 2022 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
73% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 11
Holders
10
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$40K | |
| 2 | +$20K | |
| 3 | +$16.7K | |
| 4 |
IA
IFP Advisors
Tampa,
Florida
|
+$11.8K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$5K |
Top Sellers
| 1 | -$37K | |
| 2 | -$36K | |
| 3 | -$30K | |
| 4 |
CAM
Campion Asset Management
Falls Church,
Virginia
|
-$25K |
| 5 |
Renaissance Technologies
New York
|
-$22K |